Clinical Trials Directory

Trials / Completed

CompletedNCT01323803

Eosinophilic Esophagitis Databank

Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)

Status
Completed
Phase
Study type
Observational
Enrollment
709 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
6 Months – 65 Years
Healthy volunteers
Not accepted

Summary

This study will establish a registry for participants with eosinophilic esophagitis (EoE) and create a research resource that will provide further insights into EoE.

Detailed description

Eosinophilic esophagitis (EoE) is a newly recognized chronic disease that is increasingly being diagnosed in children and adults. Many patients with EoE also have food allergies. EoE is characterized by inflammation and accumulation of a specific type of immune cell, called an eosinophil, in the esophagus. While there have been several large studies of EoE, very few have focused on the roles the immune system, genetics/heredity, and the environment in EoE. The samples and information collected from participants will help to identify and understand the genetic mechanisms underlying eosinophilic esophagitis. The Cincinnati Children's Hospital Medical Center will serve as the Central Laboratory for genetic characterization studies.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2011-03-28
Last updated
2017-08-28

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01323803. Inclusion in this directory is not an endorsement.

Eosinophilic Esophagitis Databank (NCT01323803) · Clinical Trials Directory